Clinical Trial Update: Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing sequential S-1 plus docetaxel followed by S-1 versus concurrent S-1 plus docetaxel for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hebei Tumor Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN